These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11934221)

  • 1. Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease.
    Saller B; Görges R; Reinhardt W; Haupt K; Janssen OE; Mann K
    Clin Lab; 2002; 48(3-4):191-200. PubMed ID: 11934221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin.
    Grauer A; Raue F; Ziegler R
    Exp Clin Endocrinol Diabetes; 1998; 106(4):353-9. PubMed ID: 9792470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer.
    Trimboli P; Rossi F; Baldelli R; Laurenti O; Nigri G; Ventura C; Appetecchia M; Attanasio D; Romanelli F; Guidobaldi L; Guarino M; Crescenzi A; Valabrega S
    Diagn Cytopathol; 2012 May; 40(5):394-8. PubMed ID: 21563324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
    Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
    Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
    Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada.
    Daniels GH
    Thyroid; 2011 Nov; 21(11):1199-207. PubMed ID: 21936671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study.
    Trimboli P; Cremonini N; Ceriani L; Saggiorato E; Guidobaldi L; Romanelli F; Ventura C; Laurenti O; Messuti I; Solaroli E; Madaio R; Bongiovanni M; Orlandi F; Crescenzi A; Valabrega S; Giovanella L
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):135-40. PubMed ID: 23627255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement.
    Bugalho MJ; Santos JR; Sobrinho L
    J Surg Oncol; 2005 Jul; 91(1):56-60. PubMed ID: 15999359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
    Mirallié E; Iacobone M; Sebag F; Henry JF
    Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin screening in patients with thyroid nodules. Diagnostic value.
    Schneider C; Kobe C; Schmidt M; Kahraman D; Malchau G; Faust M; Schicha H; Dietlein M
    Nuklearmedizin; 2012; 51(6):228-33. PubMed ID: 22940904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.
    Ghillani PP; Motté P; Troalen F; Jullienne A; Gardet P; Le Chevalier T; Rougier P; Schlumberger M; Bohuon C; Bellet D
    Cancer Res; 1989 Dec; 49(23):6845-51. PubMed ID: 2555054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal range of calcitonin in children measured by a chemiluminescent two-site immunometric assay.
    Verga U; Morpurgo PS; Vaghi I; Radetti G; Beck-Peccoz P
    Horm Res; 2006; 66(1):17-20. PubMed ID: 16636574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of the calcitonin assay on the definition of biochemical cure in patients with medullary thyroid carcinoma].
    Hartung-Knemeyer V; Müller S; Nagarajah J; Lahner H; Broecker-Preuss M; Bockisch A; Görges R
    Nuklearmedizin; 2012; 51(4):125-32. PubMed ID: 22526413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test".
    Niederle MB; Scheuba C; Gessl A; Li S; Koperek O; Bieglmayer C; Riss P; Selberherr A; Niederle B
    Biochem Med (Zagreb); 2018 Oct; 28(3):030710. PubMed ID: 30429678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fine-needle aspiration biopsy in the management of patients with thyroid nodules.
    Zagorianakou P; Malamou-Mitsi V; Zagorianakou N; Stefanou D; Tsatsoulis A; Agnantis NJ
    In Vivo; 2005; 19(3):605-9. PubMed ID: 15875783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased calcitonin level in thyroid nodules without medullary carcinoma.
    Gibelin H; Essique D; Jones C; Levillain P; Maréchaud R; Kraimps JL
    Br J Surg; 2005 May; 92(5):574-8. PubMed ID: 15779075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a two-site enzyme immunometric assay (EIA) for calcitonin and its application in the measurement of the hormone in normal subjects, MTC-patients and post-menopausal women.
    Seth R; Motte P; Kehely A; Wimalawansa S; Self CH; Bohuon C; Bellet D; MacIntyre I
    Horm Metab Res Suppl; 1989; 21():3-5. PubMed ID: 2680865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.